Business Description
Predictive Oncology Inc
NAICS : 339112
SIC : 3841
ISIN : US74039M3097
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.98 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.66 | |||||
Debt-to-EBITDA | -0.2 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -26.58 | |||||
Beneish M-Score | -3.1 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -40.4 | |||||
3-Year EBITDA Growth Rate | 44.5 | |||||
3-Year EPS without NRI Growth Rate | 48 | |||||
3-Year FCF Growth Rate | 45.8 | |||||
3-Year Book Growth Rate | -8.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 128.85 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -47.71 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.49 | |||||
Quick Ratio | 1.37 | |||||
Cash Ratio | 1.15 | |||||
Days Inventory | 245.22 | |||||
Days Sales Outstanding | 92.07 | |||||
Days Payable | 714.79 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -60.1 | |||||
Shareholder Yield % | -21.02 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.21 | |||||
Operating Margin % | -805.37 | |||||
Net Margin % | -802.63 | |||||
FCF Margin % | -732.12 | |||||
ROE % | -164.09 | |||||
ROA % | -93.91 | |||||
ROIC % | -260.99 | |||||
3-Year ROIIC % | 12.38 | |||||
ROC (Joel Greenblatt) % | -355.8 | |||||
ROCE % | -131.11 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.08 | |||||
PB Ratio | 1.23 | |||||
Price-to-Tangible-Book | 1.3 | |||||
EV-to-EBIT | -0.23 | |||||
EV-to-EBITDA | -0.24 | |||||
EV-to-Revenue | 1.85 | |||||
EV-to-Forward-Revenue | 0.06 | |||||
EV-to-FCF | -0.25 | |||||
Price-to-Median-PS-Value | 0.22 | |||||
Price-to-Net-Current-Asset-Value | 12.56 | |||||
Earnings Yield (Greenblatt) % | -434.78 | |||||
FCF Yield % | -218.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Predictive Oncology Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1.622 | ||
EPS (TTM) (€) | -0.731 | ||
Beta | 0 | ||
Volatility % | 43.6 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 4 | ||
12-1 Month Momentum % | -47.71 | ||
52-Week Range (€) | 4 - 9.32 | ||
Shares Outstanding (Mil) | 4.06 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Predictive Oncology Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Predictive Oncology Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Predictive Oncology Inc Frequently Asked Questions
What is Predictive Oncology Inc(FRA:S1K)'s stock price today?
When is next earnings date of Predictive Oncology Inc(FRA:S1K)?
Does Predictive Oncology Inc(FRA:S1K) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |